738
Views
6
CrossRef citations to date
0
Altmetric
Article

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort

, , , &
Pages 50-56 | Received 26 May 2017, Accepted 13 Feb 2018, Published online: 14 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nourhan Hisham Shady, Amira R Khattab, Safwat Ahmed, Miaomiao Liu, Ronald J Quinn, Mostafa A Fouad, Mohamed Salah Kamel, Abdullatif Bin Muhsinah, Markus Krischke, Martin J Mueller & Usama Ramadan Abdelmohsen. (2020) Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge (Amphimedon) Species in Green Synthesized Silver Nanoparticles Assisted by in Silico Modeling and Metabolic Profiling. International Journal of Nanomedicine 15, pages 3377-3389.
Read now

Articles from other publishers (5)

Giovanna Li Petri, Simona Di Martino & Maria De Rosa. (2022) Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors. Journal of Medicinal Chemistry 65:11, pages 7438-7475.
Crossref
Pragyan Mishra, Shibangini Beura & Rahul Modak. 2021. Bioprospecting of Enzymes in Industry, Healthcare and Sustainable Environment. Bioprospecting of Enzymes in Industry, Healthcare and Sustainable Environment 315 347 .
Qizhang Li, Zhiying Wang, Qiang Zheng & Sen Liu. (2020) Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2. Computational and Structural Biotechnology Journal 18, pages 2200-2208.
Crossref
Ewa Janczewska, Dorota Zarębska-Michaluk, Hanna Berak, Anna Piekarska, Andrzej Gietka, Dorota Dybowska, Włodzimierz Mazur, Teresa Belica-Wdowik, Witold Dobracki, Magdalena Tudrujek-Zdunek, Zbigniew Deroń, Iwona Buczyńska, Marek Sitko, Agnieszka Czauż-Andrzejuk, Beata Lorenc, Jolanta Białkowska-Warzecha, Jolanta Citko, Łukasz Laurans, Jerzy Jaroszewicz, Łukasz Socha, Olga Tronina, Brygida Adamek, Andrzej Horban, Waldemar Halota, Barbara Baka-Ćwierz, Krzysztof Tomasiewicz, Krzysztof Simon, Aleksander Garlicki, Marta Wawrzynowicz-Syczewska & Robert Flisiak. (2018) The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study. BMC Infectious Diseases 18:1.
Crossref
Jordan Chapman, Ahmed Ismail & Cerasela Dinu. (2018) Industrial Applications of Enzymes: Recent Advances, Techniques, and Outlooks. Catalysts 8:6, pages 238.
Crossref